The Chief Strategy & New Business of Brooks Automation (NASDAQ: BRKS) is Selling SharesBy Carrie Williams
In addition to David Gray, 18 other BRKS executives reported Sell trades in the last month. Following David Gray’s last BRKS Sell transaction on November 14, 2016, the stock climbed by 0.6%.
Based on Brooks Automation’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $158 million and quarterly net profit of $9.42 million. In comparison, last year the company earned revenue of $146 million and had a net profit of $6.56 million. The company has a one year high of $16.11 and a one year low of $8.33. Currently, Brooks Automation has an average volume of 544K.
The insider sentiment on Brooks Automation has been neutral according to 52 insider trades in the past three months. This sentiment is higher than the average sentiment of company insiders in this sector.
Brooks Automation, Inc. engages in the provision of automation and cryogenic solutions for multiple markets, including semiconductor capital equipment and life science biological sample management and storage. It operates its business through the following segments: Brooks Product Solutions, Brooks Global Services, and Brooks Life Science Systems. The Brooks Product Solutions segment provides a variety of products and solutions that enable improved throughput and yield in controlled operating environments. Those products include atmospheric and vacuum tool automation systems, atmospheric and vacuum robots and robotic modules and cryogenic vacuum pumping, thermal management and vacuum measurement solutions used to create, measure and control critical process vacuum applications. The Brooks Global Services segment provides an extensive range of support services including repair services, diagnostic support services and installation services in support of the products from its Brooks Product Solutions segment, which enable its customers to maximize process tool uptime and productivity. The Brooks Life Science Systems segment provides automated sample management systems for automated sample storage, equipment for sample preparation and handling, consumables, as well as parts and support services to a wide range of life science customers including pharmaceutical companies, biotechnology companies, national laboratories, research institutes and research hospitals. The company was founded in 1978 and is headquartered in Chelmsford, MA.